Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Francis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Harefuah|March 22, 2002
[Chylomicronemia syndrome]Adi Francis, Yishai Levy
International Journal of Nephrology and Renovascular Disease|May 10, 2014
Embolic renal infarction mimicking renal colicMahmud Mahamid, Adi Francis, Ali Abid, et al.
Journal of Diabetes Research|July 15, 2015
Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis PatientsInbal Dahan, Evgeny Farber, Nadia Thauho, et al.
Vaccine: X|October 27, 2023
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosisDavid Hakimian, Johnny Amer, Alaa Jammal, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2021
Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitisRifaat Safadi, Marius Braun, Adi Francis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Harefuah|March 22, 2002
[Chylomicronemia syndrome]Adi Francis, Yishai Levy
International Journal of Nephrology and Renovascular Disease|May 10, 2014
Embolic renal infarction mimicking renal colicMahmud Mahamid, Adi Francis, Ali Abid, et al.
Journal of Diabetes Research|July 15, 2015
Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis PatientsInbal Dahan, Evgeny Farber, Nadia Thauho, et al.
Vaccine: X|October 27, 2023
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosisDavid Hakimian, Johnny Amer, Alaa Jammal, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2021
Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitisRifaat Safadi, Marius Braun, Adi Francis, et al.
Pageof 1